Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2012. The document serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding changes in interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain financial performance data.
Material Changes
The only material change disclosed is an insider transaction involving Mr. P C Thomson, a Person Discharging Managerial Responsibility. On May 28, 2012, he exercised a share option to purchase 605 Ordinary Shares granted on December 1, 2008, under the GlaxoSmithKline plc ShareSave Plan at a price of £9.51 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the routine disclosure of the share option exercise.
Key Facts for Investor Verification
- Transaction Date: May 28, 2012.
- Individual: Mr. P C Thomson (Person Discharging Managerial Responsibility).
- Action: Exercise of share option for 605 Ordinary Shares.
- Exercise Price: £9.51 per share.
- Plan: GlaxoSmithKline plc ShareSave Plan (granted December 1, 2008).